The Blavatnik Harvard Life Lab is the centerpiece of the Harvard Medical School Therapeutics Initiative, which aims to help Harvard and hospital affiliated researchers transform their most promising fundamental biological discoveries into high-impact medicines faster, more efficiently, and more affordably. The initiative is a sweeping effort to advance therapeutics research, accelerate translation of discoveries into medicines, and train the inventors of future medicines.

Life Science Angels is the premier Silicon Valley based investment group investing in early stage medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health. These companies bring breakthrough technologies to address pressing unmet clinical and patient needs.Member since 2016 and Board Director and Bio/Genomics Chair 2018-2020.

Smart money for great startups. Founded in 2000, Sand Hill Angels is an active angel investment group comprised of 100 Silicon Valley executives and investors that are passionate about entrepreneurialism and the commercialization of disruptive technologies, with early stage investments in promising startups.With experience spanning all aspects of growing successful companies — from the formative stage through the management of multi-billion dollar enterprises — Sand Hill Angels seeks to add value, and to provide expertise and assistance to fledgling enterprises. Sand Hill Angels works openly and collaboratively with venture capital funds, other angel organizations, and the Bay Area ecosystem to foster the growth of technology startups.Sand Hill Angels participates in early/seed to Series A, B, C investments, as well as later stage rounds. We do not focus on specific verticals or industries, but invest in companies who have big, disruptive ideas.Board Director, 2018-2019.

Prestigious University of California at Berkeley startup accelerator.

Support medical device innovators from UCSF and beyond.

Chimera develops safe and effective CAR T cell therapeutics, using next generation control technology, against liquid and solid tumors.

Named the "Accelerator Superstar of the Year" by Venturebeat, Alchemist is a venture-backed initiative focused on accelerating the development of seed-stage ventures that monetize from enterprises.

TSI Group Capital is a family office that invests in early stage life science companies, with a focus on therapeutics development and life science tools companies.

TSI Biocomputing provides premium data analytic services to the biotech and pharmaceutical industry.

Invest in early stage digital health tech companies to improve patient care.

Ultra High Impact Biotherapeutics for Life.